𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dipeptidyl peptidase IV inhibitors for type 2 diabetes and metabolic syndrome

✍ Scribed by Paul E. Wiedeman; James M. Trevillyan

Book ID
119225977
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
173 KB
Volume
2
Category
Article
ISSN
1740-6773

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Type 2 diabetesβ€”Therapy with dipeptidyl
Type 2 diabetesβ€”Therapy with dipeptidyl peptidase IV inhibitors
✍ Hans-Ulrich Demuth; Christopher H.S. McIntosh; Raymond A. Pederson πŸ“‚ Article πŸ“… 2005 πŸ› Elsevier Science 🌐 English βš– 803 KB

The sole application of an inhibitor of the dipeptidyl peptidase DP IV (also DP 4, CD26, DPP-IV or DPP-4) to a mammal subsequently leading to improved glucose tolerance marks a major breakthrough in metabolic research bearing the potential of a new revolutionary diabetes therapy. This was demonstrat